Age (years) | 24 (20–26.5) | 26 (22.5–29) | 25.5 (19.5–31) | 33 (no IQR) |
Sex (F/M) | 6/4 | 5/4 | 6/4 | 2/3 |
FEV1 (l) | 2.6 (2.0–3.2) | 2.6 (2.1–2.9) | 2.5 (1.1–3.4) | 1.9 (no IQR) |
FEV1 (% predicted) | 70.2 (65.1–89.7) | 75.0 (65.1–94.0) | 67.2 (40.6–86.5) | 62.6 (no IQR) |
C-reactive protein (mg/ml) | 3.0 (1.0–4.0) | 4.0 (1.5–8.0) | 9.0 (2.0–15.0) | 3.0 (no IQR) |
Blood neutrophils (×109 cells/l) | 4.4 (3.2–9.7) | 4.5 (3.8–5.9) | 6.2 (4.3–9.8) | 3.4 (no IQR) |
White cell count (×109 cells/l) | 7.3 (6.4–9.9) | 8.2 (7.5–8.8) | 8.9 (7.4–13.8) | 6.7 (no IQR) |
Total cells (×106/g sputum) | 4.2 (3.2–14.4) | 5.2 (0.7–7.4) | 3.6 (0.9–12.2) | 3.1 (no IQR) |